Fischer Medical Ventures Ltd — Insider Trading, 30-03-2026: Insider Trading / SAST

Fischer Medical Ventures Limited has initiated a trading window closure for its promoters, directors, and designated persons. This restriction begins April 01, 2026, and will last until 48 hours after the company publicly declares its audited financial results for the year ended March 31, 2026. This step ensures key insiders with access to price-sensitive information cannot trade in company shares, upholding market integrity. The company will separately announce the Board Meeting date to consider these results.